L-fucose enhances anti-tumor immunity through modulation of monocyte-derived dendritic cell signaling

Although immunotherapies have emerged as standard of care for severals cancer types, their efficacy remains limited to ~30% of patients. Limited efficacy has in part been attributed to a lack of infiltrating tumor-suppressive immune cells and overabundance of immunosuppressive cell populations. To c...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of immunology (1950) Vol. 210; no. 1_Supplement; pp. 157 - 157.11
Main Authors Burton, Chase, Lester, Daniel, Lau, Eric
Format Journal Article
LanguageEnglish
Published 01.05.2023
Online AccessGet full text

Cover

Loading…